Page last updated: 2024-10-21

1,10-phenanthroline and Carcinoma, Hepatocellular

1,10-phenanthroline has been researched along with Carcinoma, Hepatocellular in 3 studies

1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research Excerpts

ExcerptRelevanceReference
"Radioembolisation of hepatocellular carcinoma with radiolabelled Lipiodol is a method of choice."5.40Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. ( Garin, E; Lepareur, N; Lopez, A; Noiret, N, 2014)
"Radioembolisation of hepatocellular carcinoma with radiolabelled Lipiodol is a method of choice."1.40Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma. ( Garin, E; Lepareur, N; Lopez, A; Noiret, N, 2014)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lopez, A1
Noiret, N1
Garin, E1
Lepareur, N1
Cichy, J1
Rose-John, S1
Potempa, J1
Pryjma, J1
Travis, J1
Czupryn, M1
Brown, WE1
Vallee, BL1

Other Studies

3 other studies available for 1,10-phenanthroline and Carcinoma, Hepatocellular

ArticleYear
Mixed-ligand complexes of yttrium-90 dialkyldithiocarbamates with 1,10-phenanthroline as a possible agent for therapy of hepatocellular carcinoma.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014, Volume: 94

    Topics: Carcinoma, Hepatocellular; Drug Stability; Ethiodized Oil; Feasibility Studies; Humans; Isotope Labe

2014
Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells.
    Journal of immunology (Baltimore, Md. : 1950), 1997, Dec-01, Volume: 159, Issue:11

    Topics: Alternative Splicing; Antineoplastic Agents; Carcinoma, Hepatocellular; Dexamethasone; Dose-Response

1997
Zinc rapidly induces a metal response element-binding factor.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Nov-01, Volume: 89, Issue:21

    Topics: Base Sequence; Carcinoma, Hepatocellular; Cell Nucleus; DNA Probes; DNA-Binding Proteins; Edetic Aci

1992